Contents

Methylisopropyllysergamide

Chemical compound

Methylisopropyllysergamide

Clinical data
Other names	(6aR,9R)- N-methyl- N-isopropyl- 7-methyl- 4,6,6a,7,8,9- hexahydroindolo- [4,3-fg] quinoline- 9- carboxamide;
ATC code	none
Legal status
Legal status	DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act US: Schedule I (isomer of LSD) Illegal in France[1]
Identifiers
IUPAC name (8β)-N-Isopropyl-N,6-dimethyl-9,10-didehydroergoline-8-carboxamide
CAS Number	100768-08-9 Y
PubChem CID	57507938
UNII	AC6WQQ5Y4B
Chemical and physical data
Formula	C20H25N3O
Molar mass	323.440 g·mol−1
3D model (JSmol)	Interactive image
SMILES C4N(C)C1Cc2c[nH]c(ccc3)c2c3C1=CC4C(=O)N(C)C(C)C
InChI InChI=1S/C20H25N3O/c1-12(2)23(4)20(24)14-8-16-15-6-5-7-17-19(15)13(10-21-17)9-18(16)22(3)11-14/h5-8,10,12,14,18,21H,9,11H2,1-4H3 Key:ROICYBLUWUMJFF-UHFFFAOYSA-N
(verify)

Methylisopropyllysergamide (lysergic acid methylisopropyl amide, MIPLA) is an analogue of LSD that was originally discovered by Albert HofmannatSandoz during the original structure-activity research into LSD. It has subsequently been investigated in more detail by the team led by David E. NicholsatPurdue University. Methylisopropyllysergamide is a structural isomer of LSD, with the alkyl groups on the amide nitrogen having been subjected to a methylene shuffle. MIPLA and its ethylisopropyl homologue are the only simple N,N-dialkyl lysergamides that approach the potency of LSD itself, being around 1/3-1/2 the potency of LSD,^[2] while all other dialkyl analogues tested (dimethyl, dipropyl, methylethyl etc.) are only around 1/10 as potent as LSD,^[3] although some N-monoalkyl lysergamides such as the sec-butyl and t-butyl derivatives were also found to show an activity profile and potency comparable to LSD,^[4] and the mono-isopropyl derivative is only slightly weaker than MIPLA. Apart from its lower potency, the hallucinogenic effects of methylisopropyllysergamide are similar to those of LSD itself, and the main use for this drug has been in studies of the binding site at the 5-HT_2A receptor through which LSD exerts most of its pharmacological effects.^[5]

See also[edit]

• Lysergic acid 2-butyl amide
• Lysergic acid 3-pentyl amide

References[edit]

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.